was read the article
array:25 [ "pii" => "S2013251416301304" "issn" => "20132514" "doi" => "10.1016/j.nefroe.2016.12.003" "estado" => "S300" "fechaPublicacion" => "2016-11-01" "aid" => "246" "copyright" => "Sociedad Española de Nefrología" "copyrightAnyo" => "2016" "documento" => "simple-article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Nefrologia (English Version). 2016;36:705" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2621 "formatos" => array:3 [ "EPUB" => 342 "HTML" => 1792 "PDF" => 487 ] ] "Traduccion" => array:1 [ "en" => array:20 [ "pii" => "S0211699516301114" "issn" => "02116995" "doi" => "10.1016/j.nefro.2016.06.010" "estado" => "S300" "fechaPublicacion" => "2016-11-01" "aid" => "246" "copyright" => "Sociedad Española de Nefrología" "documento" => "simple-article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Nefrologia. 2016;36:705" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3733 "formatos" => array:3 [ "EPUB" => 406 "HTML" => 2530 "PDF" => 797 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Comment on “Cellular and molecular aspects of diabetic nephropathy; the role of VEGF-A”" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "705" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Comentario a “Cellular and molecular aspects of diabetic nephropathy; the role of VEGF-A”" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Erol Arslan, Adem Aydın, Şeref Demirbaş, Kenan Sağlam" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Erol" "apellidos" => "Arslan" ] 1 => array:2 [ "nombre" => "Adem" "apellidos" => "Aydın" ] 2 => array:2 [ "nombre" => "Şeref" "apellidos" => "Demirbaş" ] 3 => array:2 [ "nombre" => "Kenan" "apellidos" => "Sağlam" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2013251416301304" "doi" => "10.1016/j.nefroe.2016.12.003" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251416301304?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699516301114?idApp=UINPBA000064" "url" => "/02116995/0000003600000006/v1_201611240148/S0211699516301114/v1_201611240148/en/main.assets" ] ] "itemSiguiente" => array:20 [ "pii" => "S2013251417300135" "issn" => "20132514" "doi" => "10.1016/j.nefroe.2017.01.010" "estado" => "S300" "fechaPublicacion" => "2016-11-01" "aid" => "248" "copyright" => "Sociedad Española de Nefrología" "documento" => "simple-article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Nefrologia (English Version). 2016;36:706-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3899 "formatos" => array:3 [ "EPUB" => 363 "HTML" => 2738 "PDF" => 798 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Reply to letter to editor comment on “Cellular and molecular aspects of diabetic nephropathy; the role of VEGF-A”" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "706" "paginaFinal" => "707" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Respuesta a la carta al editor referida a «Mecanismos celulares y moleculares de la nefropatía diabética, rol del VEGF-A»" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Delma Veron, Alda Tufro" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Delma" "apellidos" => "Veron" ] 1 => array:2 [ "nombre" => "Alda" "apellidos" => "Tufro" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0211699516301138" "doi" => "10.1016/j.nefro.2016.08.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699516301138?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251417300135?idApp=UINPBA000064" "url" => "/20132514/0000003600000006/v1_201702210030/S2013251417300135/v1_201702210030/en/main.assets" ] "itemAnterior" => array:20 [ "pii" => "S201325141630133X" "issn" => "20132514" "doi" => "10.1016/j.nefroe.2016.05.009" "estado" => "S300" "fechaPublicacion" => "2016-11-01" "aid" => "235" "copyright" => "Sociedad Española de Nefrología" "documento" => "simple-article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "Nefrologia (English Version). 2016;36:701-4" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4655 "formatos" => array:3 [ "EPUB" => 314 "HTML" => 3772 "PDF" => 569 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case report</span>" "titulo" => "Failed ABO incompatible high titers kidney transplant using bortezomib. Case report" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "701" "paginaFinal" => "704" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Fracaso en el uso de bortezomib en el trasplante ABO incompatible con titulos altos. Reporte de un caso" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1475 "Ancho" => 2167 "Tamanyo" => 206242 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Desensitization protocol, including the three phases of consecutive treatment. RTX, rituximab; BTZ, bortezomib; PE, plasma exchange; IVIG intravenous immunoglobulins.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Erika De Sousa-Amorim, Ignacio Revuelta, Fritz Diekmann, Joan Cid, Miquel Lozano, Federic Oppenheimer" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Erika" "apellidos" => "De Sousa-Amorim" ] 1 => array:2 [ "nombre" => "Ignacio" "apellidos" => "Revuelta" ] 2 => array:2 [ "nombre" => "Fritz" "apellidos" => "Diekmann" ] 3 => array:2 [ "nombre" => "Joan" "apellidos" => "Cid" ] 4 => array:2 [ "nombre" => "Miquel" "apellidos" => "Lozano" ] 5 => array:2 [ "nombre" => "Federic" "apellidos" => "Oppenheimer" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S0211699516300868" "doi" => "10.1016/j.nefro.2016.05.022" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699516300868?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S201325141630133X?idApp=UINPBA000064" "url" => "/20132514/0000003600000006/v1_201702210030/S201325141630133X/v1_201702210030/en/main.assets" ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Comment on “Cellular and molecular aspects of diabetic nephropathy; the role of VEGF-A”" "tieneTextoCompleto" => true "saludo" => "Dear Editor," "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "705" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Erol Arslan, Adem Aydın, Şeref Demirbaş, Kenan Sağlam" "autores" => array:4 [ 0 => array:4 [ "nombre" => "Erol" "apellidos" => "Arslan" "email" => array:1 [ 0 => "earslan89@yahoo.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "Adem" "apellidos" => "Aydın" ] 2 => array:2 [ "nombre" => "Şeref" "apellidos" => "Demirbaş" ] 3 => array:2 [ "nombre" => "Kenan" "apellidos" => "Sağlam" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Department of Internal Medicine, Gülhane Military Medical Academy, Ankara, Turkey" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "<span class="elsevierStyleItalic">Corresponding author</span>." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Comentario a “Cellular and molecular aspects of diabetic nephropathy; the role of VEGF-A”" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">We read the published article with the title of ‘Cellular and molecular aspects of diabetic nephropathy; the role of VEGF-A’<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">1</span></a> with a great interest and we found worth sharing our clinical observations through a case to contribute to the their determination.</p><p id="par0010" class="elsevierStylePara elsevierViewall">Katherine Carranza et al.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">1</span></a> have stated that the experimental conditions VEGF-A decreased or after treatment with molecules developed against VEGF, it can be observed various pathologic processes such as glomerular basement membrane damage, proteinuria, acute renal failure and thromboembolic events. Monoclonal antibodies that bind the VEGF has long been used in systemic treatment protocol of solid tumors. Recently, by ophthalmologists, intravitreal administration of anti-VEGF agents seen as the primary treatment method in conditions of age- related macular degeneration, diabetic retinopathy, retinal vein occlusion.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">2</span></a> Although systemic side effects are well known with the high dose intravenous use in cancer therapy, almost local side effects were reported associated with intraocular anti-VEGF treatment. However, despite the blood retinal barrier, anti-VEGF agents are detectable in systemic circulation after intraocular administration through uveal vessels or by aqueous humor outflow and might constitutes systemic adverse effect like nephropathy by antagonizing to VEGF-dependent pathway in glomeruli.<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">3</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">We describe a case of nephrotic syndrome that were unable to detect significant findings for etiology in first research. But with detailed history we found that she had received intravitreal anti-VEGF due to diabetic retinopathy 10 days before the occurrence of symptoms. After the exclusion of other possible causes. We thought anti-VEGF agents might be responsible. In the literature, we found only 3 cases associated with renal toxicity of intraocular anti-VEGF therapy.<a class="elsevierStyleCrossRefs" href="#bib0050"><span class="elsevierStyleSup">4–6</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">We would like to remind that even at the small quantities used in the practice of ophthalmology, anti-VEGF agents may able to cause serious systemic effects including nephropathy.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:6 [ 0 => array:3 [ "identificador" => "bib0035" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cellular and molecular aspects of diabetic nephropathy; the role of VEGF-A" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "K. Carranza" 1 => "D. Veron" 2 => "A. Cercado" 3 => "N. Bautista" 4 => "W. Pozo" 5 => "A. Tufro" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.nefro.2015.05.013" "Revista" => array:6 [ "tituloSerie" => "Nefrologia" "fecha" => "2015" "volumen" => "35" "paginaInicial" => "131" "paginaFinal" => "138" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26300505" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0040" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "R.F. Spaide" 1 => "Y.L. Fisher" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Retina" "fecha" => "2006" "volumen" => "26" "paginaInicial" => "275" "paginaFinal" => "278" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16508426" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0045" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Systemic adverse events after intravitreal bevacizumab versus ranibizumab for age-related macular degeneration: a meta-analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "W. Wang" 1 => "X. Zhang" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1371/journal.pone.0109744" "Revista" => array:5 [ "tituloSerie" => "PLOS ONE" "fecha" => "2014" "volumen" => "9" "paginaInicial" => "e109744" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25330364" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0050" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Relapse of minimal change nephrotic syndrome after intravitreal bevacizumab" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "T. Sato" 1 => "Y. Kawasaki" 2 => "T. Waragai" 3 => "T. Imaizumi" 4 => "A. Ono" 5 => "N. Sakai" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/ped.12017" "Revista" => array:6 [ "tituloSerie" => "Pediatr Int" "fecha" => "2013" "volumen" => "55" "paginaInicial" => "e46" "paginaFinal" => "e48" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23782377" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0055" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Membranous nephropathy following intravitreal injection of bevacizumab" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "H.R. Anto" 1 => "G.F. Hyman" 2 => "J.P. Li" 3 => "S. Spitalewitz" 4 => "D. Thomas" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jcjo.2011.12.024" "Revista" => array:6 [ "tituloSerie" => "Can J Ophthalmol" "fecha" => "2012" "volumen" => "47" "paginaInicial" => "84" "paginaFinal" => "86" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22333861" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0060" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Systemic and kidney toxicity of intraocular administration of vascular endothelial growth factor inhibitors" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G. Pellé" 1 => "N. Shweke" 2 => "J.P. Duong Van Huyen" 3 => "L. Tricot" 4 => "S. Hessaïne" 5 => "V. Frémeaux-Bacchi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1053/j.ajkd.2010.11.030" "Revista" => array:6 [ "tituloSerie" => "Am J Kidney Dis" "fecha" => "2011" "volumen" => "57" "paginaInicial" => "756" "paginaFinal" => "759" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21295897" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/20132514/0000003600000006/v1_201702210030/S2013251416301304/v1_201702210030/en/main.assets" "Apartado" => array:4 [ "identificador" => "35436" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/20132514/0000003600000006/v1_201702210030/S2013251416301304/v1_201702210030/en/main.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251416301304?idApp=UINPBA000064" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 2 | 1 | 3 |
2024 October | 29 | 37 | 66 |
2024 September | 39 | 22 | 61 |
2024 August | 49 | 44 | 93 |
2024 July | 37 | 19 | 56 |
2024 June | 43 | 28 | 71 |
2024 May | 45 | 23 | 68 |
2024 April | 47 | 34 | 81 |
2024 March | 27 | 22 | 49 |
2024 February | 31 | 38 | 69 |
2024 January | 25 | 24 | 49 |
2023 December | 19 | 16 | 35 |
2023 November | 31 | 25 | 56 |
2023 October | 23 | 21 | 44 |
2023 September | 23 | 27 | 50 |
2023 August | 30 | 16 | 46 |
2023 July | 29 | 25 | 54 |
2023 June | 26 | 14 | 40 |
2023 May | 37 | 22 | 59 |
2023 April | 22 | 9 | 31 |
2023 March | 36 | 28 | 64 |
2023 February | 29 | 10 | 39 |
2023 January | 17 | 16 | 33 |
2022 December | 47 | 29 | 76 |
2022 November | 34 | 29 | 63 |
2022 October | 34 | 31 | 65 |
2022 September | 37 | 26 | 63 |
2022 August | 42 | 42 | 84 |
2022 July | 22 | 34 | 56 |
2022 June | 32 | 24 | 56 |
2022 May | 29 | 28 | 57 |
2022 April | 35 | 39 | 74 |
2022 March | 42 | 38 | 80 |
2022 February | 39 | 36 | 75 |
2022 January | 28 | 31 | 59 |
2021 December | 38 | 41 | 79 |
2021 November | 29 | 32 | 61 |
2021 October | 38 | 43 | 81 |
2021 September | 41 | 32 | 73 |
2021 August | 25 | 34 | 59 |
2021 July | 34 | 23 | 57 |
2021 June | 33 | 31 | 64 |
2021 May | 29 | 31 | 60 |
2021 April | 73 | 49 | 122 |
2021 March | 38 | 30 | 68 |
2021 February | 23 | 28 | 51 |
2021 January | 33 | 16 | 49 |
2020 December | 17 | 12 | 29 |
2020 November | 35 | 14 | 49 |
2020 October | 19 | 25 | 44 |
2020 September | 19 | 15 | 34 |
2020 August | 40 | 13 | 53 |
2020 July | 18 | 17 | 35 |
2020 June | 13 | 27 | 40 |
2020 May | 30 | 20 | 50 |
2020 April | 33 | 17 | 50 |
2020 March | 23 | 16 | 39 |
2020 February | 27 | 15 | 42 |
2020 January | 37 | 24 | 61 |
2019 December | 31 | 22 | 53 |
2019 November | 27 | 20 | 47 |
2019 October | 20 | 10 | 30 |
2019 September | 25 | 16 | 41 |
2019 August | 9 | 11 | 20 |
2019 July | 16 | 27 | 43 |
2019 June | 19 | 15 | 34 |
2019 May | 21 | 10 | 31 |
2019 April | 19 | 24 | 43 |
2019 March | 27 | 16 | 43 |
2019 February | 26 | 14 | 40 |
2019 January | 20 | 15 | 35 |
2018 December | 76 | 38 | 114 |
2018 November | 140 | 17 | 157 |
2018 October | 125 | 17 | 142 |
2018 September | 63 | 10 | 73 |
2018 August | 54 | 16 | 70 |
2018 July | 62 | 16 | 78 |
2018 June | 69 | 17 | 86 |
2018 May | 69 | 14 | 83 |
2018 April | 106 | 7 | 113 |
2018 March | 95 | 8 | 103 |
2018 February | 81 | 7 | 88 |
2018 January | 90 | 8 | 98 |
2017 December | 63 | 5 | 68 |
2017 November | 49 | 14 | 63 |
2017 October | 30 | 5 | 35 |
2017 September | 37 | 10 | 47 |
2017 August | 56 | 7 | 63 |
2017 July | 46 | 8 | 54 |
2017 June | 53 | 7 | 60 |
2017 May | 44 | 9 | 53 |
2017 April | 27 | 3 | 30 |
2017 March | 25 | 4 | 29 |
2017 February | 25 | 6 | 31 |